WA
RPRX icon

WPG Advisers’s Royalty Pharma RPRX Stock Holding History

WPG Advisers’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Hold
20
– – ﹤0.01% 1311
2026
Q1 		$959 Hold
20
– – ﹤0.01% 1264
2025
Q4 		$773 Hold
20
– – ﹤0.01% 1329
2025
Q3 		$706 Hold
20
– – ﹤0.01% 1324
2025
Q2 		$721 Sell
20
-1,248
-98% -$41.3K ﹤0.01% 1306
2025
Q1 		$39.5K Buy
1,268
+56
+5% +$1.77K 0.04% 320
2024
Q4 		$30.9K Buy
+1,212
New +$32.1K 0.03% 374

Other funds holding RPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WPG Advisers's RPRX Position: Q2 2026 in Review

WPG Advisers held its Royalty Pharma (RPRX) position steady in Q2 2026 at 20 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

WPG Advisers first reported a position in RPRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $39.5K in Q1 2025. 296 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • WPG Advisers held 20 shares of Royalty Pharma worth $1.12K as of Q2 2026.
  • WPG Advisers left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1311 holding.
  • WPG Advisers first reported a position in Royalty Pharma in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Royalty Pharma position peaked at $39.5K in Q1 2025.
  • 296 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.